Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

NCT01467427 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia B

Interventions

DRUG: nonacog beta pegol

Sponsor

Novo Nordisk A/S